Why the Refunds & Returns Policy Begins With Two Documented Batches
The published Refunds & Returns Policy at Research Sciences is deliberately narrow. Because research materials are specialist and perishable, the shop states that it does not accept returns once an order has been dispatched, and that refunds are considered only where there is damage, incorrect supply or a genuine quality issue. That wording matters for materials managers and laboratory researchers alike: a claim is not judged on how strongly someone feels about a vial, but on whether the evidence supports the category being claimed. In practice, the strongest evidence is a comparison between two documented batches — the batch in hand and the batch it is being measured against, whether that is an earlier delivery from the same catalogue entry or the batch described on the accompanying Certificate of Analysis (CoA).
A documented batch is more than a vial in a box. It is the combination of the order confirmation, the tracked dispatch record, the label reference, the CoA supplied with that specific batch, and the storage history from arrival onwards. UK dispatch is described as next-working-day via Royal Mail Tracked 24, with delivery presented as an estimate rather than a guarantee, so the tracking record also functions as a timeline. When two batches are compared, each element should line up side by side, because a discrepancy in one document is far easier to assess than a general description of dissatisfaction.
The vial label is central here. Research Sciences describes a label reference that combines the SKU code and an expiry date, in a format such as BPC10-03/27, linking the vial to its corresponding CoA. Quoting that reference in any correspondence removes ambiguity about which physical item is being discussed. Researchers should also understand what an Internal Test Reference (ITR) does and does not prove. The FAQs note that restocked products may carry the same ITR as earlier stock, and that an ITR links to associated sample testing reports; it does not confirm that separate deliveries came from the same production lot or that they were independently tested separately. Two vials with matching ITRs are therefore not automatically two comparable batches.
Packaging is a related trap. Vial cap colours and other packaging details may vary between deliveries, and the shop states plainly that cap colour is not an indicator of identity, analytical quality or manufacturing origin. A comparison built on cap colour is not a batch comparison at all.
Building a Side-by-Side Batch Record Before You Contact Support
What to Capture When the Parcel Arrives
Photograph the outer packaging, the tracking label, the vial itself and any seal or crimp before the vial is opened. Note visible transit damage, condensation, or evidence of temperature excursion. Record the month and year of receipt alongside the label reference and the catalogue item name, then reconcile those against the order confirmation. From that point, handling becomes part of the record: lyophilised material is stored at −20 °C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided. Reconstituted material is described as less stable and is held at 2–8 °C for short-term laboratory use only. All of this sits inside an in-vitro workflow; the materials are not for human or veterinary use, and the reconstitution calculator offered on product pages is a laboratory tool for diluent volume and assay concentration, not a dosing aid.
What to Capture From the Paperwork
Each batch should be documented by its own CoA, described by the shop as HPLC-based for purity and identity, within a wider testing framework that the About page characterises as including heavy metals and endotoxin evaluation. The homepage lists “CoAs Janoshik Analytical Reports”, but the operative document is always the CoA that accompanies the specific batch, and the researcher should open it rather than rely on a category page. Published headline wording such as “≥99% Verified Purity”, “UK Research Materials Over 99.1% Purity” and “3,000+ UK Orders” reflects the shop’s own published figures at the time of reading and should be reconfirmed on the live site; they are not a substitute for the batch-specific certificate. Where the paperwork and the published listing need to be reconciled, the live catalogue at Peptide uk and the CoA supplied with the specific vial are the two documents to read together. Research Sciences is the trading name, with Imperial Peptides UK described in the FAQs as a brand operated by the same parent company, so older paperwork bearing the earlier name is not by itself a discrepancy — but it should be noted in the comparison record.
Quality Claims: Separating a Batch Discrepancy From Handling Variables
Damage and Incorrect Supply
Damage claims are the most straightforward to document: packaging photographs, seal integrity, tracking timeline and a description of the condition on arrival, submitted promptly. Incorrect supply claims require a three-way check between the order confirmation, the label reference and the physical item — catalogue name, stated quantity and reference code should all agree. Where the wrong catalogue entry has been dispatched, the comparison is between what was ordered and what was received, not between two chemical profiles. Neither category requires analytical interpretation, which is why both are usually resolved more quickly when the paperwork is complete and the label reference is quoted in the first message.
Quality Issues
Quality claims are more demanding, because a genuine batch discrepancy must be distinguished from an artefact of handling or assay design. The comparison should be framed against the CoA: does the delivered vial match the identity and purity described for that reference, and does its appearance match the lyophilised powder the listing describes? Observations should be recorded in laboratory terms — diluent used, concentration prepared for the in-vitro assay, visual appearance after reconstitution, and the assay conditions — rather than in general impressions.
Handling variables should be ruled out first and transparently: ambient temperature before opening, moisture exposure, light exposure, freeze–thaw history, storage duration after reconstitution and diluent choice. It is also worth recording that the FAQs describe trace mannitol as an excipient in all peptides, and that blended peptides are not supplied, so a claim involving a combination product falls outside the catalogue structure entirely. Two documented batches, each with its label reference, its own CoA and a dated handling record, give the shop something it can actually assess against its own testing documentation. A narrative without those anchors gives it very little. Materials remain research-use-only throughout, are not medicines, medical devices, injectables, treatments or food supplements under UK law, and are not supplied for therapeutic, clinical or diagnostic purposes; the purchaser remains responsible for lawful use, safe handling, storage, disposal and COSHH compliance.
